News

The VRFCAT is a new virtual reality measure that estimates patients’ ability to go through daily challenges using realistic, simulated environments. NeuroCog Trials had finished phase I of the

As a dispatch distributor, Fisher BioServices will offer cryogenic storage and will distribute Pluristem’s PLX cells for clinical trials and preclinical sites across the globe. Pluristem is currently

The OpTmizer CTS, as a human ex vivo (outside the body) tissue and cell culture processing application develops therapeutic T-cells to treat diseases including cancer, infectious diseases such as AIDS

The acquisition is expected to improve Accenture’s existing clinical services capabilities such as clinical data management, clinical programming and safety case processing and add regulatory submission services. Accenture

The study will evaluate the safety and plasma pharmacokinetics of multiple doses of RG3039, an orally bioavailable small molecule inhibitor of an RNA processing enzyme called DcpS, in

The two identical 52-week, double-blind, randomised, placebo-controlled trials with matching twice-daily 150mg dosing, inclusion criteria and endpoints enrolled a total of 970 patients in 20 countries. The annual

As part of the agreement, Galderma will carry on the ongoing NVC-422 clinical development program for impetigo and NovaBay will receive double-digit royalties on net sales of products.

The once-daily investigational medicine FF/VI is used to treat chronic obstructive pulmonary disease (COPD). The Marketing Authorisation Application for FF/VI for COPD and asthma has also been validated

Teijin Pharma is planning to begin phase I clinical trials for ADC3680 in Japan in April 2013, while Pulmagen Therapeutics has already begun phase II clinical trials for